The Neuroscience Research Unit is excited to have Michael Ehlers, M.D., Ph.D., join the team as Senior Vice President and Chief Scientific Officer.

Mike is a world class scientist whose deep understanding of neurobiology will be a powerful asset as we build on the progress in our Neuroscience Research Unit and apply new thinking to deliver novel therapeutics in Alzheimer’s disease, autism, and schizophrenia. His experience in the field and his passion for transforming medical outcomes are a winning combination in helping Pfizer create the industry’s leading pipeline of neuroscience medicines.

Check out Mike’s recent interview with Nature to find out why Mike chose to join Pfizer and how he became hooked on neuroscience.

Read more...

 

About Pfizer Neuroscience

Different people. Different perspectives. One common commitment.

At Pfizer Neuroscience, we know we can make a difference in the quality of life for millions of individuals worldwide with neurologic and psychiatric disorders. We also understand that your talent is key to accomplishing this goal.

A commitment to therapies for brain disorders

Among the most devastating disorders of our time, neurologic and psychiatric diseases combine to cause more disability than any other disease area. At Pfizer, we have a deep industry-leading commitment to understanding the origins of brain disorders and to developing innovative medicines that effectively treat Alzheimer’s disease, Parkinson’s disease, depression, schizophrenia, Huntington’s disease, autism, stroke recovery, Tourette’s syndrome, sensorineural hearing loss, and the rare but devastating transthyretin familial amyloid polyneuropathy.

We are creating an integrated drug discovery engine that uses cutting edge science to accelerate a focused portfolio through value inflection points by:

  • Using the clinic as Pfizer’s laboratory
  • Integrating across technology platforms and disease areas
  • Leveraging the external environment
  • Building an industry-leading scientifically focused, entrepreneurial culture

Statement from the CSO

What is Pfizer Neuroscience?

Led by Chief Scientific Officer, Michael Ehlers, Pfizer Neuroscience is a group of exceptional basic and clinical neuroscientists supported by an extensive network of internal and external partners. The group is organized by therapeutic focus with operational enablers:

Search for Neuroscience Careers at Pfizer:

Pfizer offers the opportunity to work on exciting and ground-breaking research in neuroscience., access to unparalleled resources and world-class facilities, and the opportunity to work with some of the brightest and most driven individuals in the biopharmaceutical industry.

Search Now